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this stage, the therapy of choice is closed-chest drainage
and antibiotics. During the fibrinopurulent phase (stage
II) frank pus accumulates, and fibrin deposits will pro-
duce a pleural peel and loculation of fluid. Expansion of
the lung is restricted, and simple treatment with closed-
chest drainage is no longer effective. Without surgical
intervention, the empyema will progress to the so-
called organizing phase (stage III). This stage is charac-
terized by a migration of fibroblasts from the pleura
with deposits of collagen fibers and a thickening of the
layers (peel), further restricting the movement of the
lung, chest wall, and diaphragm. Rib resection and
pleural drainage in the fibrinopurulent phase (stage II)
and decortication in the organizing phase (stage III) has
been the common surgical treatment.2 Satisfactory
results in the management of empyema have been re-
ported in the recent literature with the use of video-
D espite the introduction of broad-spectrum antibi-otics and the declining incidence of tuberculosis,
thoracic empyema remains a serious problem.
Empyema begins with an exudate (stage I),1 which is
caused by an increased capillary permeability of the
pleura in response to contamination. Because of its low
viscosity, the lung remains mobile within the fluid. In
Objective: Despite modern diagnostic methods and appropriate treat-
ment, pleural empyema remains a serious problem. Our purpose was to
assess the feasibility and efficacy of the video-assisted thoracoscopic
surgery in the management of nontuberculous fibrinopurulent pleural
empyema after chest tube drainage treatment had failed to achieve the
proper results. Methods: We present a prospective selected single institu-
tion series including 45 patients with pleural empyema who underwent
an operation between March 1993 and December 1996. Mean preoper-
ative length of conservative management was 37 days (range, 8–82
days). All patients were assessed by chest computed tomography and
ultrasonography and underwent video-assisted thoracoscopic debride-
ment of the empyema and postoperative irrigation of the pleural cavity.
Results: In 37 patients (82%), video-assisted thoracoscopic debridement
was successful. In 8 cases, decortication by standard thoracotomy was
necessary. There were no complications during video-assisted thoracic
operations. The mean duration of chest tube drainage was 7.1 days
(range, 4–140 days). At follow-up (n = 35) with pulmonary function tests,
86% of the patients treated by video-assisted thoracic operation showed
normal values; 14% had a moderate obstruction and restriction without
impairment of exercise capacity, and no relapse of empyema was
observed. Conclusions: Video-assisted thoracoscopic debridement repre-
sents a suitable treatment for fibrinopurulent empyema when chest tube
drainage and fibrinolytics have failed to achieve the proper results. In an
early organizing phase, indication for video-assisted thoracic operation
should be considered in due time to ensure a definitive therapy with a
minimally invasive intervention. For pleural empyema in a later orga-
nizing phase, full thoracotomy with decortication remains the treatment
of choice. (J Thorac Cardiovasc Surg 1999;117:234-8)
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assisted thoracoscopic surgery (VATS).3-8 In this pros-
pective study, we report about our experience with
VATS on 45 patients with nontuberculous empyema
after chest tube drainage and antibiotic because prima-
ry therapeutic interventions had failed. We analyze the
difference between computed tomography (CT) and
ultrasonography in clinical staging of empyema with
relevance to the decision-making process, and we pro-
pose new treatment guidelines for thoracic empyema.
Patients and methods
From March 1993 to December 1996, 52 patients were
referred to our institution with the clinical and radiologic
diagnosis of nontuberculous empyema persisting after initial
treatment with closed-chest tube drainage and antibiotics. At
admission, 7 of these 52 patients showed a marked function-
al disturbance, and radiologically an encased lung with a
thick fibrous peel was evident (stage III empyema). These
patients were not considered for VATS because they required
decortication by standard thoracotomy and were excluded
from this prospective evaluation. 
The remaining 45 patients (25 male, 20 female; average
age, 52 years [range, 13–86 years]) had a mean of 37 days
(range, 8–82 days) from the onset of symptoms until referral
to our institution. However, chest tube drainage plus fibri-
nolytic agents and parenteral antibiotics were insufficient
treatment for these empyemas, demonstrated by persisting
clinical symptoms (fever) and the ultrasonographic findings
of multiloculated pleural fluid on admission. Clinical data,
including symptoms, cause of empyema, associated diseases,
or predisposing conditions were recorded. In addition, all
patients had standard posteroanterior and lateral chest radi-
ographs and CT (axial, 10-mm thick contiguous slices after
the administration of iodinated contrast agent) and ultra-
sonography of the chest (intercostal transverse sections with
a 3.5 MHz curved-array transducer). The diagnosis of empye-
ma was based on grossly purulent fluid at thoracentesis, pos-
itive pleural fluid cultures, or positive Gram stain. All patients
underwent VATS debridement with general anesthesia and
double-lumen intubation (Carlens tube). Patients were placed
in lateral decubitus position. A 2-cm skin incision was per-
formed at the level of the largest fluid collection, as deter-
mined by ultrasonography. The intercostal muscles were
divided, and biopsy specimens of the the parietal pleura were
obtained for histopathologic examination. After the fluid had
been evacuated and sent for immediate Gram stain and cul-
ture, adhesions between the lung and the chest wall were bro-
ken, and the video thoracoscope was inserted through a 10-
mm trocar. The second trocar was placed under direct vision
of the camera. Loculated fluid collections were disrupted
both bluntly and by sharp preparation until the entire cavity
was freed. After irrigation with saline solution, the remaining
areas of debris were dislodged. Irrigation was repeated until
the cavity was clean. The instruments were removed, and the
lung was ventilated with a pressure of 30 to 40 cm H2O to
check for leaks, residual cavities, and the efficacy of lung
expansion. Two 32F chest tubes were finally inserted through
the thoracoscopy sites. If one of the sites was at an unfavor-
able location for draining, the chest tube was inserted through
a separate incision.
The pleural cavity was irrigated daily with 1000 mL saline
solution. The solution was injected with a 50-mL syringe
through the apical 32F chest drain. During the procedure,
which lasted 15 minutes, the fluid was drained through the
caudal chest tube where a 30–cm H2O aspiration was applied.
After the procedure both chest tubes were connected to the
suction system. Antibiotics were not added to the saline solu-
tion because the irrigation was aimed to remove debris of fib-
rin and blood clots from the pleural cavity, making use of its
mechanical action. When the effluent fluid clarified (normal-
ly 3–5 days after VATS) and daily fluid cultures remained
sterile, chest drains were removed and the administration of
antibiotics was discontinued. Because it takes 2 days for bac-
terial cultures to yield a result, the duration of chest tube
placement turns out to be 2 days longer than necessary.
During this time, irrigation is performed. Subsequently, each
patient participated in a mandatory and intensive program of
general mobilization and specific respiratory therapy. At least
3 months after the patient’s discharge, we performed a fol-
low-up check that included a clinical examination, chest
radiography, and pulmonary function tests. Patients whose
condition required a secondary intervention, such as decorti-
cation, lung resection, or thoracostomy, were not considered
for follow-up.
Results
The causes of nontuberculous empyema of the 45
patients treated by VATS are shown in Table I. In 39
cases (87%) empyema was due to bronchopulmonary
infection. Two patients with idiopathic spontaneous
pneumothorax experienced an empyema because of
bronchopleural fistula. Complications of minor surgi-
cal procedures, such as infected thoracentesis and
hemothorax after chest tube drainage, caused 3 empye-
mas. Twenty-seven patients (60%) had associated dis-
eases or predisposing conditions (ie, chronic obstruc-
tive pulmonary disease, bronchiectasis, malnutrition,
and alcoholism). Fever and chest pain were leading
symptoms in 27 patients (60%), followed by dyspnea
(n = 21, 47%), and cough (n = 14, 31%). The empye-
ma cavity was multiloculated in 30 patients (67%) and
Table I. Causes of empyema in 45 patients treated by
VATS
Secondary to bronchopulmonary infection 39
Previous minor surgical intervention 3
Spontaneous pneumothorax and bronchopleural fistula 2
Idiopathic 1
Total 45
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uniloculated in 15 patients (33%). Bacteria could be
isolated in the empyema fluid of 21 patients (47%).
There were no intraoperative complications. Mean
duration of chest tube drainage was 7.1 days (range, 4-
140 days); the average hospital stay 10.7 days (range,
6-140 days), including a program of general mobiliza-
tion and specific respiratory therapy. Five patients
(11%) had postoperative complications. Two patients
experienced a prolonged air leak (>7 days) that was
treated conservatively. A pneumothorax after chest tube
removal had to be treated by the reinsertion of a chest
tube at the bedside; one case of pneumonia was treated
with antibiotics and resolved in 1 week. One patient
experienced the development of endocarditis 4 weeks
after VATS, which led to septic emboli in the brain and
upper and lower extremities. This patient required
mechanical ventilation for several weeks and showed
residual hemiplegia 6 months after the operation. 
In 8 cases the lung failed to expand during VATS
because of a thick fibrous peel; the empyema was
therefore upstaged and full thoracotomy was per-
formed. In 2 cases lung resection was added to decorti-
cation because of destroyed lobes with persistent bron-
chopleural fistulae. One patient in poor condition
required thoracostomy.
CT findings and surgical staging of empyema corre-
lated in 28 patients (62%). In 17 of 45 cases (38%), the
empyema was understaged because the CT was unable
to detect loculations or because the thick fibrous peel
encasing the lung was not visualized. Ultrasonography
was able to properly stage 37 of 45 patients (82%). In
8 cases (18%) gas inclusions in the pleural fluid pro-
hibited a satisfactory ultrasonographic examination
leading to incorrect staging.
At follow-up 35 patients were examined. Eight
patients whose conditions required secondary surgical
measures (ie, thoracotomy) were not considered; 2
additional patients with uneventful recovery who left in
good condition with normal findings on chest radiogra-
phy could not be reached. The average time at follow-
up was 20.1 months after hospital discharge (range,
3–48 months). None of the patients required surgical
treatment after discharge or complained of serious
problems related to the empyema or its therapy. In 7
cases (20%) examination of the chest radiograph
revealed a moderate fibrothorax. In 5 of these 7
patients, pulmonary function tests demonstrated a
moderate obstruction (mean forced expiratory volume
in 1 second, 76% of predicted value; range, 56%–88%)
and restriction (mean vital capacity, 72% of predicted
value; range, 51%–83%) without impairment of the
exercise capacity. The remaining 30 patients (86%)
showed normal static lung volumes (vital capacity,
90% or more of predicted value), normal forced expi-
ratory volume in 1 second (90% or more of predicted
value) and normal exercise capacity.
Discussion
Successful management of thoracic empyema
requires prompt treatment with drainage and antibi-
otics. Early recognition and aggressive treatment
should be adopted by all physicians to prevent chronic-
ity of the disease. Surgical intervention should be con-
sidered for patients with loculated effusion, particu-
larly if the lung does not expand under drainage. Even
if our series is lacking comparative groups, the present
results emphasize the efficacy of VATS in the treatment
of pleural empyema when drainage and fibrinolytics
have failed and standard thoracotomy represents the
only suitable therapeutic alternative. With the advan-
tage of a less invasive surgical technique, VATS ensures
equal results to standard thoracotomy because it allows
a precise inspection of the whole pleural cavity and a
debridement can be performed under direct vision. In
our series, no empyema relapse or complication oc-
curred. Functional intermediate term results show that
86% of the patients treated by VATS had normal pul-
monary function tests and that chest radiographs were
normal in 80% of cases. The remaining patients had a
moderate obstructive and restrictive ventilatory deficit.
Table II. Current world literature survey on thoracoscopic treatment of empyema
Duration Chest tube Hospital stay Success Conversion Complications Deaths 
Authors n (days) Stage (days) (days) (%) (%) (%) (%)
Angelillo et al3 31 11 II 4.1 6.7 90 10 16 3
Hornick et al4 14 19 II — 7.8 71 29 7 0
Landreneau et al5 76 9 II/III 3.3 7.4 83 17 3 6.6
Ridley and Braimbridge14 30 — II/III 10.7 — 60 40 — 13
Sendt et al6 10 — — 8.5 16.3 100 0 10 0
Striffeler et al7 67 <21 II 4.1 12.3 72 28 4 4
Wait et al8 11 — II 5.8 8.7 91 0 0 9
Present study 45 37 II/III 7.1 10.7 82 18 11 0
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They did, however, not have an impairment of exercise
capacity.
Conservative treatment of the empyema with intra-
pleural fibrinolytics was demonstrated to be a valid
therapeutic option for patients with loculated effusions
not older than 12 days.9 The success rate decreased to
61% if the empyema was 20 days old.10 There is no
experience on the efficacy of fibrinolytic agents for
older empyemas. In our opinion, this treatment alone is
unsuited if symptoms of empyema last for more than 4
weeks as in our series.
In our series of 45 patients with an average onset of
symptoms of 37 days before operation, 8 patients (18%)
needed secondary interventions in the form of a decor-
tication by standard thoracotomy, and no patients died.
Reports in the literature on the suitability of VATS for
empyema in this stage are poor.5 Success rates between
60% and 100% of cases were reported, but results were
better if the length of the preoperative medical manage-
ment did not exceed 2 weeks (Table II).
Reexpansion of the lung, which is of great importance
for outcome, can be checked by VATS at the end of the
intervention. If the lung is still entrapped and the patient’s
general condition allows, an immediate decortication by
standard thoracotomy during the same anesthesia
should be performed. In all cases of incomplete re-expan-
sion of the lung, important postoperative supportive mea-
sures include constant aspiration of the drainages and
specific respiratory therapy for the diaphragm. 
Because of the introduction and improvement of
VATS, the currently used empyema classification does
not seem to add substantial information to the decision-
making process. An early organizing phase could be
successfully treated by VATS according to our experi-
ence and the literature, whereas a later organizing
phase would usually require thoracotomy and decorti-
cation. Therefore clinical staging of empyema still re-
mains a challenge.
History, clinical examination, and bacteriologic find-
ings are of good diagnostic value but of little value for
empyema staging. Extreme values of pleural fluid
chemistry (pH < 7.2; glucose < 40 mg/dL; lactate dehy-
drogenase > 1000 IU/L; protein > 5.0 mg/dL) correlate
with loculated effusions but not with empyema.11 In
accordance with the literature,7,11-13 we experienced that
the CT scan provides insufficient information to distin-
guish between a loculated pleural effusion, as in an
early organizing phase, and a pleural peel requiring
some amount of decortication, as in a later organizing
phase (Fig 1, A). Conversely, ultrasonography in experi-
enced hands provides major additional information with
this regard. It clearly detects loculations, and the thick-
ness of the fibrinous deposits encasing the lung can be
precisely visualized (Fig 1, B). In contrast to CT assess-
ment of the underlying lung, parenchyma is not possi-
ble, and gas inclusions in the pleural fluid may disable
a satisfactory ultrasonographic exploration. Empyema
assessment by ultrasonography requires considerable
experience; when the chest is shrunk after empyema,
the intercostal spaces are often too narrow to allow a
satisfactory examination. Therefore ultrasonography
should be performed in all patients with pleural empye-
ma in combination with rather than instead of CT.
Morphologic information provided by thoracic ultra-
sonography and the versatility of VATS require the
reconsideration of the current staging proposed in 1962
and the restructuring of treatment guidelines for tho-
racic empyema. Patients without loculated fluid collec-
Fig 1. A, Axial contrast-enhanced CT of the chest at the floor
of the left atrium shows gas inclusions, thickening, and
increased contrast uptake of the parietal pleura (arrows) in a
42-year-old patient with stage II empyema. No loculations
are detectable. B, Chest ultrasonography of the same patient
as in A reveals loculations (arrow) and a thickened visceral
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tion are treated at bedside by chest tube drainage. If the
lung does not expand with drainage and fibrinolytics or
ultrasonography shows a loculated fluid collection, the
patient should be treated with minimally invasive tech-
niques. If ultrasonography demonstrates an encased
lung or the lung fails to expand during VATS, the patient
should undergo decortication by full thoracotomy.
In addition to the advantages of a less invasive surgi-
cal procedure, the favorable functional results at the
intermediate term substantiate the authenticity of the
VATS procedure as an alternative to the previous “gold
standard” in the treatment of fibrinopurulent and early
organizing empyema. Decortication by standard thora-
cotomy remains the treatment of choice for more
advanced empyemas, when the lung is entrapped by a
thick fibrous peel. Previous VATS debridement does
not rule out a secondary surgical measure, but it may
represent a bridging measure in septic patients until
they can undergo safe decortication.
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Commentary
Cassina and associates have reported on 37 patients
in whom video-thoracoscopic (VATS) debridement of
parapneumonic fibrinopurulent empyemas was suc-
cessful. It is their contention that VATS represents a
suitable therapeutic option when conservative mea-
sures such as thoracentesis, tube drainage, or fibri-
nolytics have failed. VATS is advocated over early tho-
racotomy or rib resection drainage because it can be
performed with low mortality and fewer complications.
In addition, 86% of patients treated by VATS showed
good functional recovery, as evidenced by follow-up
pulmonary function testing.
Although this series supports the principle of early
surgical intervention, it raises important questions con-
cerning the timing of surgery in relation to the stage of
empyema. How does one differentiate simple inflam-
matory reaction likely to respond to antibiotics and
drainage from early organization? How does one dif-
ferentiate between the very acute stage where pleural
fluid is thin and the purulent stage where fibrin is
deposited over pleural surfaces? Since the duration and
severity of illness are often unreliable determinants,
what are the roles of imaging (free-flowing fluid versus
loculations), fluid biochemistry (pH < or > 7.0), or
fluid bacteriology? These difficult issues are still unre-
solved, although some clarification may come from a
panel of experts currently working with the American
College of Chest Physicians to review and redefine the
terminology used to stage empyemas, as well as the
role of the various treatment strategies. This task is dif-
ficult, however, because of the lack of experimental
data, as well as the lack of prospective randomized tri-
als looking at one therapy versus another.
As pointed out by the authors of this article, VATS is a
straightforward technique that can achieve the goals of
evacuation of pus, debridement, disruption of loculations
containing fibrin clots and membranes, full lung expan-
sion, adequate dependent drainage, and space oblitera-
tion. Because it is minimally invasive, VATS is also an
ideal procedure for many of these critically ill patients
who are at high surgical risk because of their illness,
prior debilitating conditions, or immunosuppressed sta-
tus. It is probably true to say that, to date, debridement
of fibrinopurulent empyemas represents one of the true
indications for therapeutic VATS techniques.
Jean Deslauriers, MD, FRCS(C)
Sainte-Foy, Quebec, Canada
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